These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 17137553)
1. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model. Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553 [TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711 [TBL] [Abstract][Full Text] [Related]
3. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model. Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057 [TBL] [Abstract][Full Text] [Related]
4. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model. Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934 [TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Kreimann EL; Itoiz ME; Longhino J; Blaumann H; Calzetta O; Schwint AE Cancer Res; 2001 Dec; 61(24):8638-42. PubMed ID: 11751376 [TBL] [Abstract][Full Text] [Related]
6. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398 [TBL] [Abstract][Full Text] [Related]
7. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer. Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233 [TBL] [Abstract][Full Text] [Related]
8. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch. Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550 [TBL] [Abstract][Full Text] [Related]
9. "Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model. Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Quintana J; Santa Cruz GA; Trivillin VA; Schwint AE Radiat Res; 2011 Apr; 175(4):463-72. PubMed ID: 21294607 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology. Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740 [TBL] [Abstract][Full Text] [Related]
12. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch. Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008 [TBL] [Abstract][Full Text] [Related]
13. Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval. Monti Hughes A; Pozzi EC; Heber EM; Thorp S; Miller M; Itoiz ME; Aromando RF; Molinari AJ; Garabalino MA; Nigg DW; Trivillin VA; Schwint AE Oral Oncol; 2011 Nov; 47(11):1017-22. PubMed ID: 21840244 [TBL] [Abstract][Full Text] [Related]
14. Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model. Monti Hughes AM; Pozzi EC; Thorp S; Garabalino MA; Farías RO; González SJ; Heber EM; Itoiz ME; Aromando RF; Molinari AJ; Miller M; Nigg DW; Curotto P; Trivillin VA; Schwint AE Oral Dis; 2013 Nov; 19(8):789-95. PubMed ID: 23410091 [TBL] [Abstract][Full Text] [Related]
15. Ploidy analysis of field cancerization and cancer development in the hamster cheek pouch carcinogenesis model. Raimondi A; Cabrini R; Itoiz ME J Oral Pathol Med; 2005 Apr; 34(4):227-31. PubMed ID: 15752258 [TBL] [Abstract][Full Text] [Related]
16. Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels. Molinari AJ; Thorp SI; Portu AM; Saint Martin G; Pozzi EC; Heber EM; Bortolussi S; Itoiz ME; Aromando RF; Monti Hughes A; Garabalino MA; Altieri S; Trivillin VA; Schwint AE Acta Oncol; 2015 Jan; 54(1):99-106. PubMed ID: 24960584 [TBL] [Abstract][Full Text] [Related]